EU’s IVDR Clinical Evidence Comes Under The Microscope
Executive Summary
Do you know what is required when it comes to providing clinical evidence for IVDs in the EU? Consultants at Maetrics explain how, given that the majority of IVDs are about to find themselves in a higher risk class, there is a steep learning curve ahead. There will also be a scramble for the limited notified body resources available.
You may also be interested in...
Expert Panel Discusses Impact Of Stricter US, EU Data Privacy Laws On Medtech Industry
An expert panel at the AdvaMed Digital MedTech Conference discussed the impact of new privacy rights and data protection, in particular CCPA and GDPR, on medtech companies and ways for companies to deal with the challenge of compliance.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.